Obesity Pathogenesis: Insights from Molecular and Cellular Biology

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 281

Special Issue Editor


E-Mail Website
Guest Editor
Biomedical Research Institute of Málaga (IBIMA), Málaga, Spain
Interests: obesity; type 2 diabetes; adipose tissue; browning; angiogenesis; cell biology; animal physiology; hypertension; metabolism; insulin resistance; human physiology; nutrition; metabolic diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The global prevalence of obesity, characterized as the excess accumulation of adipose tissues, has reached epidemic proportions. Obesity is a significant risk factor in th development of a variety of chronic diseases, working to induce type 2 diabetes, fatty liver, cardiovascular diseases, neurodegenerative disorders, osteoarthritis, sleep apnea, and certain types of cancer.

The pathophysiology of obesity has been widely investigated, and an increasing number of signal transduction pathways have been found to be involved in obesity, making it possible to fight obesity in a more efficient and precise manner. These transduction pathways are believed to arise through a complex interplay between genetic and epigenetic predisposition, environment, and nutrition. In this regard, microRNAs (miRNAs) have emerged as key regulators of epigenetics pathways. Numerous studies have exhibited that miRNAs control different aspects of metabolic diseases such as the development of organs, release of and sensitivity to hormones, and are involved in an innumerable cellular process regulation, including proliferation, differentiation, DNA repair, apoptosis, and metabolism. Moreover, the discovery of circulating miRNAs, easily detectable in plasma and other body fluids, has highlighted their potential for use as both endocrine signaling molecules and disease indicators, or as potential biomarkers for the diagnosis or prognosis of obesity and associated diseases. Thus, therapeutic strategies that target these micro molecules could have great potential to fight obesity and other associated problems.

Dr. Rajaa El Bekay
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop